Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Subject tyrosine kinase

Multiple interactions are also being demonstrated between the traditional second-messenger pathways and the MAPK cascades. Free (3y G protein subunits, generated upon activation of receptors coupled to the G family, lead to activation of the ERK pathway. The mechanism by which this occurs, which may involve an interaction between the subunits and Ras or Raf, is a subject of intensive research (see Ch. 19). In addition, increases in cellular Ca2+ concentrations lead to stimulation of the ERK pathway, apparently via phosphorylation by CaMKs of proteins, for example She and Grb, that link growth factor receptor tyrosine kinases to Ras. Activation of the... [Pg.410]

Only three amino acids have a hydroxyl functional group in their side chain tyrosine, serine and threonine. Some kinases target only tyrosine residues (tyrosine kinases) whereas others may phosphorylate serine or threonine (Ser/Thr kinases). An enzyme protein (the substrate for the kinase) may have several tyrosine, serine or threonine residues within its primary sequence, but only some of these are subject to phosphorylation by a particular kinase (see Figure 3.6)... [Pg.65]

Phospholipase C, which occurs in different subtypes in the cell, is a key enzyme of phosphatide inositol metabohsm (for cleavage specificity, see Fig. 5.24). Two central signaling pathways regulate phosphohpase C activity of the cell in a positive way (Fig. 6.4). Phospholipases of type CP (PL-CP) are activated by G-proteins and are thus linked into signal pathways starting from G-protein-coupled receptors. Phosphohpases of type Y (PL-Cy), in contrast, are activated by transmembrane receptors with intrinsic or associated tyrosine kinase activity (see Chapter 8, Chapter 10). The nature of the extracellular stimuli activated by the two major reaction pathways is very diverse (see Fig 6.4), which is why the phosphohpase C activity of the cell is subject to multiple regulation. [Pg.220]

Fig. 6.4. Formation and function of diacylglycerol and Ins(l,4,5)P3. Formation of diacylglycerol (DAG) and Ins(l,4,5)P3 is subject to regulation by two central signaling pathways, which start from transmembrane receptors with intrinsic or associated tyrosine kinase activity (see Chapters 8 11) or from G-protein-coupled receptors. DAG activates protein kinase C (PKC, see Chapter 7), which has a regulatory effect on ceU proliferation, via phosphorylation of substrate proteins. Ins(l,4,5)P3 binds to corresponding receptors (InsPs-R) and induces release of Ca from internal stores. The membrane association of DAG, PtdIns(3,4)P2 and PL-C is not shown here, for clarity. Fig. 6.4. Formation and function of diacylglycerol and Ins(l,4,5)P3. Formation of diacylglycerol (DAG) and Ins(l,4,5)P3 is subject to regulation by two central signaling pathways, which start from transmembrane receptors with intrinsic or associated tyrosine kinase activity (see Chapters 8 11) or from G-protein-coupled receptors. DAG activates protein kinase C (PKC, see Chapter 7), which has a regulatory effect on ceU proliferation, via phosphorylation of substrate proteins. Ins(l,4,5)P3 binds to corresponding receptors (InsPs-R) and induces release of Ca from internal stores. The membrane association of DAG, PtdIns(3,4)P2 and PL-C is not shown here, for clarity.
Quinazolines are of great interest in the pharmaceutical industry as protein tyrosine kinase inhibitors. Dener et al 8 described a synthesis starting from 2-methoxybenzaldehyde, Wang, or Rink resins. With the aldehyde resin reductive aminations were undertaken to yield polymer-bound secondary amines (Fig. 7). The latter were subjected to 2,4-dichloro-6,7-dimethoxyquinazoline to give the 4-amino-substituted derivatives. These were then allowed to react with primary or secondary amines at 135-140° in the presence of DBU in DMA. As a result of a detailed scope and limitation study, Dener et al,28 note that some bifunctional amines, such as piperazine, give to some extent dimeric derivatives. [Pg.446]

Frohna P, Lu J, Eppler S, et al. Evaluation of the absolute oral bioavailability and bioequivalence oferlotinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in a randomized, crossover study in healthy subjects. J Clin Pharmacol 2006 46(3) 282-90. [Pg.333]

Finally SHRs are subject to phosphorylation, althou the role of phosphorylation is not yet clear in all cases. SHRs are substrates of serine/threonine kinases, and, at least in the case of oestrogen receptors, also of tyrosine kinases. Moreover, transcriptionally active SHRs are phosphorylated by a DNA-dependent kinase. SHRs can also respond indirectly to hormones that signal through the second messenger, cAMP, because the co-activator CBP is a target of the cAMP-dependent serine/threonine kinase, PKA. Phosphorylation of CBP enhances SHR activity. [Pg.200]

Protein tyrosine phosphatases are part of the signaling by receptor tyrosine kinases and, as such, are subject to multiple regulatory influences (Fig. 8.22). The mechanisms are those already highlighted in previous Chapters as central elements of the regulation of activity of signal molecules. [Pg.348]

Insulin receptors. Iti.suLin receptors are membrane-spanning glyco-proieins consisting of two a-siibimits and two fl-subunits linked cova-Icnily by disulphide bonds. After insulin binds to the u-subuntt. the insulin-receptor complex enters the cell, where the insulin is destroyed hy lysosomal enzymes. The internalization of the insulin-receptor complex underlies the (iown-re)(ulan(jii of receptors that is produced hy high levels of insulin (e.g. in obese subjects). The binding of insulin to the receptors activate.s the tyrosine kinase activity of the p-subunii and initiates a complex chain of reactions that lead to the effecLs of insulin. [Pg.79]

The compound cinnamtannin B-1 reduced thrombin-induced aggregation in platelets from type 2 diabetic subjects (Bouaziz et al. 2007). The same compound reduced thrombin-evoked microtubular remodeling and activation of the tyrosine kinases Btk and pp60(src), which leads to inhibition of platelet aggregation (Ben Amor et al. 2007). [Pg.502]


See other pages where Subject tyrosine kinase is mentioned: [Pg.968]    [Pg.33]    [Pg.205]    [Pg.131]    [Pg.239]    [Pg.240]    [Pg.416]    [Pg.67]    [Pg.401]    [Pg.200]    [Pg.257]    [Pg.545]    [Pg.149]    [Pg.92]    [Pg.242]    [Pg.161]    [Pg.168]    [Pg.92]    [Pg.968]    [Pg.627]    [Pg.52]    [Pg.83]    [Pg.291]    [Pg.151]    [Pg.149]    [Pg.141]    [Pg.410]    [Pg.116]    [Pg.298]    [Pg.391]    [Pg.487]    [Pg.164]    [Pg.67]    [Pg.711]    [Pg.173]    [Pg.512]    [Pg.398]    [Pg.247]    [Pg.61]   
See also in sourсe #XX -- [ Pg.504 ]




SEARCH



Subject kinase

Subject tyrosine

Tyrosine kinases

Tyrosines tyrosine kinase

© 2024 chempedia.info